ALDH1A3 and microcephaly: Whereas, among Cas9 injected control embryos only 8.4% developed severe microcephaly, targeting the aldh1a3 gene with sgR3 resulted in a significant three-fold increase (25%) of embryos with severe microcephaly (Figure 7).